KS

Karpas Strategies Portfolio holdings

AUM $319M
This Quarter Return
+5.11%
1 Year Return
+14.42%
3 Year Return
+16.08%
5 Year Return
+58.83%
10 Year Return
+119.75%
AUM
$200M
AUM Growth
+$200M
Cap. Flow
+$164K
Cap. Flow %
0.08%
Top 10 Hldgs %
41.14%
Holding
120
New
2
Increased
16
Reduced
17
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$427B
$17.2M 8.56%
141,470
-120
-0.1% -$14.6K
MMP
2
DELISTED
Magellan Midstream Partners, L.P.
MMP
$12.1M 6.01%
158,646
BN icon
3
Brookfield
BN
$98.3B
$8.56M 4.27%
258,735
+3,235
+1% +$107K
MRK icon
4
Merck
MRK
$210B
$8.02M 4%
139,188
CMPR icon
5
Cimpress
CMPR
$1.55B
$7.23M 3.61%
78,180
-1,376
-2% -$127K
SCHW icon
6
Charles Schwab
SCHW
$174B
$6.87M 3.43%
271,355
BIP icon
7
Brookfield Infrastructure Partners
BIP
$14.6B
$6.16M 3.07%
136,167
+125
+0.1% +$5.66K
BPY
8
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$5.84M 2.91%
259,820
WPC icon
9
W.P. Carey
WPC
$14.7B
$5.63M 2.81%
81,050
GE icon
10
GE Aerospace
GE
$292B
$4.96M 2.48%
157,655
-900
-0.6% -$28.3K
CMCSA icon
11
Comcast
CMCSA
$125B
$4.69M 2.34%
71,972
+9
+0% +$587
WFC icon
12
Wells Fargo
WFC
$263B
$4.29M 2.14%
90,561
+22
+0% +$1.04K
XOM icon
13
Exxon Mobil
XOM
$487B
$4.08M 2.04%
43,533
BRK.B icon
14
Berkshire Hathaway Class B
BRK.B
$1.09T
$3.95M 1.97%
27,266
+200
+0.7% +$29K
PFE icon
15
Pfizer
PFE
$141B
$3.89M 1.94%
110,491
+100
+0.1% +$3.52K
LBTYK icon
16
Liberty Global Class C
LBTYK
$4.07B
$3.87M 1.93%
135,178
+16,088
+14% +$461K
EEQ
17
DELISTED
Enbridge Energy Management Llc
EEQ
$3.69M 1.84%
160,549
+4,308
+3% +$99.1K
DIS icon
18
Walt Disney
DIS
$213B
$3.53M 1.76%
36,125
-115
-0.3% -$11.3K
OKS
19
DELISTED
Oneok Partners LP
OKS
$3.27M 1.63%
81,650
BEP icon
20
Brookfield Renewable
BEP
$7.2B
$3.11M 1.55%
104,250
TXN icon
21
Texas Instruments
TXN
$184B
$3M 1.5%
47,935
-65
-0.1% -$4.07K
USB icon
22
US Bancorp
USB
$76B
$2.98M 1.49%
73,821
T icon
23
AT&T
T
$209B
$2.73M 1.36%
63,180
USG
24
DELISTED
Usg
USG
$2.6M 1.3%
96,600
BMY icon
25
Bristol-Myers Squibb
BMY
$96B
$2.32M 1.16%
31,600